Please see full Prescribing Information for WYOST.

References: 1. WYOST. Prescribing information. Sandoz Inc. 2. US Food and Drug Administration. FDA Approves First Interchangeable Biosimilars to Prolia and Xgeva to Treat Certain Types of Osteoporosis and Prevent Bone Events in Cancer. 2024. Accessed March 14, 2025. https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-first-interchangeable-biosimilars-prolia-and-xgeva-treat-certain-types-osteoporosis-and

All trademarks and trade names are the property of their respective owners.

© 2025 Sandoz Inc.
100 College Road West, Princeton, NJ 08540
MLR-1861-US     05/2025